Rowlandmiller & PARTNERS.ADV Invests $117,000 in The Clorox Company (NYSE:CLX)

Rowlandmiller & PARTNERS.ADV purchased a new position in The Clorox Company (NYSE:CLX) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 716 shares of the company’s stock, valued at approximately $117,000.

A number of other institutional investors also recently made changes to their positions in CLX. Sunbelt Securities Inc. raised its holdings in shares of Clorox by 19.4% in the first quarter. Sunbelt Securities Inc. now owns 2,355 shares of the company’s stock worth $361,000 after acquiring an additional 382 shares during the last quarter. GoalVest Advisory LLC acquired a new position in shares of Clorox in the first quarter worth $31,000. Wealthcare Advisory Partners LLC purchased a new stake in shares of Clorox in the first quarter valued at $242,000. Toth Financial Advisory Corp grew its position in shares of Clorox by 15.3% in the first quarter. Toth Financial Advisory Corp now owns 10,169 shares of the company’s stock valued at $1,557,000 after purchasing an additional 1,351 shares during the period. Finally, Baker Ellis Asset Management LLC purchased a new stake in shares of Clorox in the first quarter valued at $214,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.51% of the company’s stock.

Clorox Trading Down 0.1 %

NYSE:CLX opened at $158.92 on Friday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The business’s 50 day moving average is $160.25 and its two-hundred day moving average is $145.43. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.09. The company has a market cap of $19.74 billion, a PE ratio of 82.34, a P/E/G ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. On average, analysts predict that The Clorox Company will post 6.64 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Analysts Set New Price Targets

CLX has been the subject of a number of research reports. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. DA Davidson reissued a “neutral” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Wells Fargo & Company lowered their price target on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Finally, TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 target price for the company. Six research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $150.14.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.